Results 81 to 90 of about 100,300 (318)

Safety of Drug-Eluting Stents

Reviews in Cardiovascular Medicine, 2010
Significant evolution in catheter-based technologies for percutaneous coronary intervention has occurred since the introduction of coronary balloon angioplasty by Andreas Grüntzig in 1977. As balloon angioplasty was supplanted by bare metal stents and subsequently drug-eluting stents (DES), randomized comparative clinical trials have demonstrated a ...
openaire   +2 more sources

Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Management of coronary perforation in bifurcation lesions with covered stents remains challenging. Aims We aimed to describe a proper practice and toolbox for “jailed‐branch” management after covered stent deployment. Methods Using a bench model, we tested various wires with a 120° angulated microcatheter for their ability to ...
Rayyan Hemetsberger, Anass Maaroufi, Kevin Hamzaraj, Judit Andreka, Mohammad Abdelghani, Serdar Farhan, Daniel Lootz, Johannes Gollmer, Nader Mankerious, Christian Hengstenberg, Tom W. Johnson, Gabor G. Toth   +11 more
wiley   +1 more source

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)

Revista Colombiana de Cardiología, 2012
Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj  

Endovascular Stenting for Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: From Diagnosis to Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Pulmonary vein stenosis (PVS) is an uncommon but serious complication of atrial fibrillation (AF) ablation, often misinterpreted as primary pulmonary disease. Timely identification is essential to prevent irreversible injury and to guide appropriate referral for interventional management. Case Presentations Through the discussion of
Cristina Aurigemma, Marco Busco, Francesco Bianchini, Gabriella Locorotondo, Francesca Graziani, Annalisa Pasquini, Enrico Romagnoli, Mattia Lunardi, Lazzaro Paraggio, Francesco Varone, Andrea Smargiassi, Bruno Iovene, Riccardo Marano, Carlo Trani, Francesco Burzotta   +14 more
wiley   +1 more source

Design and testing of hydrophobic core/hydrophilic shell nano/micro particles for drug-eluting stent coating [PDF]

, 2018
In this study, we designed a novel drug-eluting coating for vascular implants consisting of a core coating of the anti-proliferative drug docetaxel (DTX) and a shell coating of the platelet glycoprotein IIb/IIIa receptor monoclonal antibody SZ-21.
A Arsiwala, A Bierhalz, A Tan, AW Heldman, B Almería, B O’brien, B O’Brien, C Stettler, CJ Pan, CJ Sweeney, CL Song, D Sun, DM Saylor, E Boersma, E Camenzind, ES Park, ES Thian, F Danhier, GY An, H Zhang, HG Wang, J Kanzer, J Riegger, J Yang, J Zhang, JB Slee, JJ Wykrzykowska, JM Lee, JV Natarajan, K Kolandaivelu, KH Bønaa, KS Lim, M Gawaz, M Zamani, M Zamani, MK Dong, MP Skinner, MT Ali, PS Douglas, PW Erruys, RH Müller, RK Aggarwal, RL Wilensky, S Freiberg, S Garg, S Hossfeld, S Jang, S Lee, S Mcginty, S Meng, S Puricel, S Yasuda, SJ Liu, T Inoue, T Nakano, TM Ko, U Baber, X Ma, X Wu, X Xi, Y Cao, YH Lee, Z Yang   +62 more
core   +1 more source

Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan

Kidney Medicine
Rationale & Objective: We aimed to study the comparative effectiveness of percutaneous coronary intervention with drug-eluting stent and coronary artery bypass grafting in patients receiving dialysis.
Szu-Yu Pan, Ju-Yeh Yang, Nai-Chi Teng, Yun-Yi Chen, Shi-Heng Wang, Chien-Lin Lee, Kang-Lung Chen, Yen-Ling Chiu, Shih-Ping Hsu, Yu-Sen Peng, Yung-Ming Chen, Shuei-Liong Lin, Likwang Chen   +12 more
doaj   +1 more source

Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

Arquivos Brasileiros de Cardiologia, 2014
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%.
Denise Oliveira Pellegrini, Vitor Osório Gomes, Ricardo Lasevitch, Luis Smidt, Marco Aurélio Azeredo, Priscila Ledur, Rodrigo Bodanese, Leonardo Sinnott, Emílio Moriguchi, Paulo Caramori   +9 more
doaj   +1 more source

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo

Bioactive Materials, 2020
Pharmacokinetic analyses were performed using 20 pigs for 120-days implantation, while one sirolimus-eluting stent was implanted into one of their coronary artery.
Shanshan Chen, Zhifeng Yao, Yongbiao Guan, Hui Yang, M. Babar Shahzad, Yizhe Wu, Bingchun Zhang, Li Shen, Ke Yang   +8 more
doaj   +1 more source

Development of coronary stents using advanced results of materials science and technology [PDF]

, 2004
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János, Major, L., Nyitrai, Zs., Puskás, Zs.   +3 more
core  

Use of balloon catheter dilation and steroid-eluting stent in light and severe rhinosinusitis of frontal sinus: a multicenter retrospective randomized study [PDF]

, 2018
OBJECTIVE: Frontal sinus surgery has an increased rate of re-stenosis, if compared to other sinuses, that mainly depends on recurrent inflammation and abnormal scarring at the frontal recess; its reduction represents one of the keys of therapeutic ...
Azimonti, Dario, CAVALIERE, CARLO, DE VINCENTIIS, Marco, Dragonetti, Alberto, Franzetti, Andrea, MINNI, Antonio, RALLI, MASSIMO, ROSATI, DAVIDE, SCIUTO, Antonino   +8 more
core   +1 more source